ABNIB LAPATINIB TABLETS

Get a Price/Quote

MOQ : 1 Bottle

ABNIB LAPATINIB TABLETS Specification

Indication
Indicated for the treatment of HER2-positive breast cancer in combination with other agents

Pacakaging (Quantity Per Box)
30 tablets/box

Origin of Medicine
Pharmaceutical formulation, India

Dosage Form
Tablet

Salt Composition
Lapatinib

Drug Type
Allopathic

Ingredients
Lapatinib

Physical Form
Tablets

Function
Tyrosine kinase inhibitor used for anti-cancer treatment

Recommended For
Breast cancer patients, specifically HER2-positive metastatic breast cancer

Dosage
250 mg per tablet (as per packaging image); Dosage as directed by oncologist

Dosage Guidelines
Administer as prescribed by a qualified healthcare professional

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

ABNIB LAPATINIB TABLETS Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 30 TABLETS

About ABNIB LAPATINIB TABLETS

ABNIB LAPATINIB TABLETS represent a top-tier solution for HER2-positive metastatic breast cancer therapy. Highly recommended by oncologists and cancer specialists, this heroic formulation offers wondrous efficacy through its virtuoso action as a tyrosine kinase inhibitor. ABNIB LAPATINIB (250 mg per tablet), manufactured by Abnib Pharmaceuticals Pvt Ltd, is supplied as yellow film-coated tablets in bottles containing 30 tablets. For hospital and specialist application only, this allopathic medicine requires a prescription. Carefully stored below 30C and protected from light and moisture, ABNIB LAPATINIB ensures reliability and safety for adult patients.

Applications & Surface of Use

ABNIB LAPATINIB TABLETS are used by cancer specialists and hospitals to treat adults diagnosed with HER2-positive metastatic breast cancer. Its primary application lies within clinical oncology settings, administered orally as part of combination therapy. The tablets film-coated surface ensures easy ingestion and protects the active ingredient. Exclusively recommended for healthcare professionals, its targeted action maximizes therapeutic potential for eligible breast cancer patients.

Sample Policy & Main Market Supply

ABNIB LAPATINIB TABLETS follow a transparent sample policy for eligible medical institutions, empowering professionals to evaluate this anti-neoplastic hero. Products are shipped securely with robust packaging to ensure integrity during transportation. With reliable supply ability, Abnib Pharmaceuticals caters to hospitals, distributors, exporters, and wholesalers across India. Main domestic markets benefit from rapid delivery and secure shipping processes, supporting prompt availability for specialists and patients nationwide.

FAQs of ABNIB LAPATINIB TABLETS:

Q: How should ABNIB LAPATINIB TABLETS be administered?

A: ABNIB LAPATINIB TABLETS should be administered orally, exactly as prescribed by a qualified oncologist. Dosage must follow the recommendations on the packaging or tailored directions from your healthcare provider.

Q: What are the primary benefits of using ABNIB LAPATINIB TABLETS?

A: The main benefit of ABNIB LAPATINIB TABLETS is their targeted action against HER2-positive metastatic breast cancer, making them a vital part of combination therapy options for eligible adult patients.

Q: When should these tablets not be used?

A: ABNIB LAPATINIB TABLETS are not suitable for children and should not be used without a prescription. They are intended solely for hospital and cancer specialist use and should be avoided if you have certain pre-existing liver conditions, unless advised otherwise by your doctor.

Q: Where can ABNIB LAPATINIB TABLETS be sourced?

A: These tablets are available through hospitals, licensed distributors, exporters, suppliers, traders, and wholesalers across India. Always ensure procurement from authorized channels to guarantee product quality.

Q: What is the process for secure shipping and transportation of ABNIB LAPATINIB TABLETS?

A: ABNIB LAPATINIB TABLETS are shipped securely in robust packaging to protect from light, moisture, and physical damage, ensuring safe transportation to medical facilities and healthcare providers nationwide.

Q: What side effects may occur with ABNIB LAPATINIB TABLETS?

A: Common side effects include diarrhea, rash, nausea, fatigue, and hepatotoxicity. Patients should be monitored regularly by healthcare professionals, and any concerning symptoms should be promptly reported.

Tell us about your requirement